Biological features were mostly evaluated in malignant NB: MYCN gene status was assayed in 183 cases and found amplified in 13 (7%) and segmental chromosomal abnormalities (SCA) were assayed in 129 tumors with 29 (23%) having segmental aberrations. The gene discussed is MYCN; the disease is neuroblastoma.